[Functional organization ant therapeutic potential of the endogenous cannabinoid system].
Churiukanov
M V
MV
Pharmacology Department, Sechenov Medical Academy, ul. Bol'shaya Pirogovskaya 2, Moscow, 119992 Russia. churukanov@mmascience.ru
Churiukanov
V V
VV
D000700:Analgesics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators / Q000502:physiology*; D002186:Cannabinoids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004361:Drug Tolerance; D006801:Humans; D008024:Ligands; D010146:Pain / Q000188:drug therapy / Q000378:metabolism; D043882:Receptors, Cannabinoid / Q000502:physiology
D000700:Analgesics; D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D008024:Ligands; D043882:Receptors, Cannabinoid